By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Vanqua Bio to Present at Upcoming Scientific Conferences
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Vanqua Bio to Present at Upcoming Scientific Conferences
Vanqua Bio to Present at Upcoming Scientific Conferences
Health

Vanqua Bio to Present at Upcoming Scientific Conferences

GlobeNews Wire
Last updated: 03/06/2025 4:39 PM
GlobeNews Wire
Published: 03/06/2025
Share
SHARE

CHICAGO, June 03, 2025 (GLOBE NEWSWIRE) — Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim Phase 1 data for its lead clinical program, VQ-101, at two upcoming scientific conferences – the GBA1 Meeting 2025, which will take place in Montreal, Canada June 5-7, 2025 and the European Academy of Neurology, taking place in Helsinki, Finland June 21-24, 2025.

Vanqua Bio GBA1 Conference Presentation Information:
Title: VQ-101, A Small Molecule Allosteric Activator of Glucocerebrosidase (GCase) Demonstrates Robust And Sustained Target Engagement In Humans
Session date and time: ​June 5th 11:00am EDT
Presenter: Dr. Dan Ysselstein, Head of Biology

Vanqua Bio EAN Conference ePresentation Information:
Title: The allosteric activator of glucocerebrosidase, VQ-101, shows sustained activation of lysosomal GCase in humans
Session date and time: June 23rd 2:30pm EEST
Presenter: Dr. Maurizio Facheris, CMO

About VQ-101

VQ-101 is a novel, orally administered, fully CNS-penetrant allosteric activator of glucocerebrosidase (GCase). VQ-101 is initially being investigated in GBA-Parkinson’s (GBA-PD) and idiopathic Parkinson’s disease (iPD). By restoring GCase activity to healthy levels, VQ-101 aims to address the underlying genetic mechanism of disease in GBA-PD and slow or stop the progression of disease. Initial Phase 1 results with VQ-101 demonstrated sustained lysosomal GCase activation in healthy volunteers by more than 75%. In preclinical studies in patient derived neurons, 50%+ GCase activation resulted in significant blockage of the accumulation of alpha synuclein, the pathogenic hallmark of PD. A Phase 1b study in patients with PD, with and without GBA mutations, is ongoing.

About Vanqua Bio

Founded in 2019 and headquartered in Chicago, Vanqua Bio is a biopharmaceutical company dedicated to discovering and developing next-generation medicines that have the potential to transform the lives of patients with neurodegenerative and inflammatory diseases. Our technology platform utilizes human genetics and patient-derived CNS cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction or aberrant activation of the innate immune system. Initially, we are targeting glucocerebrosidase (GCase) as a potential treatment for Parkinson’s disease (PD). Additional programs address overactivation of the innate immune system in peripheral and central inflammatory disorders, including renal, dermatologic and neurodegenerative diseases. For more information, go to www.vanquabio.com.

 
ProSearch Experts to Share Insights on Legal Discovery, Essential Skills for Legal Teams, and More at Upcoming Webinars and Events
Let There Be Light: Vivid Sydney 2025 Kicks Off
AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology
International Athletes Forum 2025: how to follow live
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes
TAGGED:bioconferencespresentscientificuncategorizedupcomingvanqua
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
ALL4 Mining: Certified Leader in Secure Crypto Cloud Mining Launches New Mobile App
Technology

ALL4 Mining: Certified Leader in Secure Crypto Cloud Mining Launches New Mobile App

GlobeNews Wire
GlobeNews Wire
06/07/2025
DRML Miner Launches Innovative USDC Cloud Mining Platform: Experience Daily Rewards and Referral Bonuses at Zero Cost
GOVY AirCab Makes Global Debut, GAC Unveils “Land-Air Matrix” at 2025 International Automotive & Supply Chain Expo (Hong Kong)
Altri to Acquire a Majority Stake in AeoniQ to Scale World’s First Industrial Production of Climate Positive Textile Yarn
Major Magic! Grace Kim Captures The Amundi Evian Championship in Playoff Thriller
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?